Download
1 / 9
90 likes | 384 Views
Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Report provides the gene therapy targets which are close to 190 with the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. For more information : http://bit.ly/1wpCUQ0
E N D
Category : Pharmaceuticals-Healthcare Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape Browse Complete Report –http://www.aarkstore.com/pharmaceuticals-healthcare/94496/gene-therapy-insight-pipeline-assessment-technology-trend-and-competitive-landscape .
Summary Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Report provides the gene therapy targets which are close to 190 with the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety DelveInsight Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view. Reason to Buy
Report facts DelveInsight Report, Gene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape provides in depth insights into the gene therapy. It has covered 300+ Gene Therapies for 15 different therapy areas including Oncology, Central Nervous System, Genetic Disorders, Ophthalmology, Immunology and other therapy areas. Approximately in 290+ Indications extensive research is ongoing for which Oncology stands for the highest Indication explored in gene therapy so far. The Gene Therapy Report has covered 125+ companies ranging from Small to Big Pharma working in different therapeutic areas of gene therapy utilizing 90+ innovative technology platforms for getting the first mover advantage. Any approved therapy for a given therapeutic domain poses to be a ground-breaking discovery and a significant relief for patients suffering from it. The Report is also giving insights about the vectors usage in Gene therapy which is approximately 59% for viral vectors, 24% for RNAi therapeutics and 17% for Non Viral vectors. The DelveInsight Gene Therapy Report is also giving early winners of the gene therapy market using DelveInsight proprietary Matrix Model. .
Reason to Buy • Complete Market and Pipeline intelligence and complete understanding over therapeutics development for gene therapy • Devise corrective measures for pipeline projects by understanding Therapy area specific gene therapies • Developing strategic initiatives to support your gene therapy development activities. • Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business. • Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope • Evaluate the marketing and pipeline strategy for gene therapies and their Funding availabilities. • Identifying the upcoming leaders in the gene therapy market in the coming years. • Getting a first mover advantage by identifying the early market winners for clinical and preclinical gene therapies. .
Reports Highlights: • Global Gene Therapy Overview & Pipeline Insights • Trends in gene therapy partnering deals • Current Prominent Research Areas and Key Players • Companies Targeting Prominent Therapeutic Areas • Number of Gene Therapies in Clinical Trials • Number of Gene Therapies by Vectors used • Technology and their innovative Companies • Early Market Winners for Gene Therapy .
Table Of Content Introduction Global Gene Therapy Market & Pipeline Insight Market Highlight Gene Therapy- An Upcoming Innovation of Genetic Medicines Internationally Recognized Gene Symbols Driving Factors for Growing Popularity of Gene Therapy Market Manacles for Gene Therapy Current Research Therapeutic Areas in Gene Therapy Market Ex vivo and In vivo Approaches of Gene Therapy Types of Vectors developed for Gene Therapy Marketed and Pipeline Drugs for Gene Therapy Marketed Products Scenario for Gene Therapies Rexin G Profile Technology Description Funding Agreement Gendicine Profile Technology Description Funding Agreement Glybera Profile Technology Description .
RelatedReports • Cigna-HealthSpring : Company Profile and SWOT Analysis • Global Neurosurgery Market 2015-2019 • Active Pharmaceutical Ingredients (API) Market in India 2015-2019 • MEI Pharma, Inc. (MEIP) - Financial and Strategic SWOT Analysis Review • RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis Review • UMeWorld Limited (ALRXF) - Financial and Strategic SWOT Analysis Review • AntriaBio, Inc. (ANTB) - Financial and Strategic SWOT Analysis Review • Semperit AG Holding (SEM) - Financial and Strategic SWOT Analysis Review • Pfizer Limited, India (PFIZER) - Financial and Strategic SWOT Analysis Review • Recordati S.p.A. (REC) - Financial and Strategic SWOT Analysis Review .
Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape Published: Jan 2015 : 778 Pages Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. .
